Bionik Laboratories Raises $6.2 Million

Bionik Laboratories is an innovative medical-robotics company that develops healthcare solutions for patients with restricted physical mobility.

TORONTO, Feb. 27, 2015 -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware corporation (the "Company"), announced today that it acquired Bionik Laboratories, Inc., a Toronto corporation ("Bionik Laboratories"), and completed the sale to qualified accredited investors of units consisting of its common stock and warrants for aggregate gross proceeds of approximately $6.2 million. Shares of the Company's common stock will continue to be quoted on the OTC Markets under the symbol "DWTPD" until FINRA's approval of the ticker "BNKL."


Bionik Laboratories is an innovative medical-robotics company that develops healthcare solutions for patients with restricted physical mobility.

Peter Bloch, CEO of Bionik Laboratories, stated, "Our team at Bionik Labs is focused and dedicated to deploying cutting edge solutions that will assist mobility impaired people. As a company, we are committed to improving the lives of hundreds of thousands of people and we are excited to be in the forefront of this new and developing technology."

The securities sold in the private placement have not been registered under the Securities Act of 1933 and may not be offered, sold or resold absent registration or an applicable exemption from registration under such Act.

The Company intends to file a Current Report on Form 8-K with the Securities and Exchange Commission with more detailed information in accordance with the SEC rules.

About Bionik Laboratories
Founded in 2010 by Michal Prywata and Thiago Caires, Bionik Laboratories (http://www.Bioniklabs.com), a medical device and robotics company, core focus is robotic exoskeleton technology for users with mobility impairments. The technology provides the ability for users to rehabilitate effectively by being able to actually walk with the help of the technology. Bionik Laboratories has researched, developed and tested its primary product, The ARKE, an exoskeleton device that allows paraplegics and other mobility impaired individuals to stand up, walk and rehabilitate in a more effective way than current manual rehabilitation methods.

Featured Product

BitFlow Introduces 6th Generation Camera Link Frame Grabber: The Axion

BitFlow Introduces 6th Generation Camera Link Frame Grabber: The Axion

BitFlow has offered a Camera Link frame grabbers for almost 15 years. This latest offering, our 6th generation combines the power of CoaXPress with the requirements of Camera Link 2.0. Enabling a single or two camera system to operate at up to 850 MB/S per camera, the Axion-CL family is the best choice for CL frame grabber. Like the Cyton-CXP frame grabber, the Axion-CL leverages features such as the new StreamSync system, a highly optimized DMA engine, and expanded I/O capabilities that provide unprecedented flexibility in routing. There are two options available; Axion 1xE & Axion 2xE. The Axion 1xE is compatible with one base, medium, full or 80-bit camera offering PoCL, Power over Camera Link, on both connectors. The Axion 2xE is compatible with two base, medium, full or 80-bit cameras offering PoCL on both connectors for both cameras. The Axion-CL is a culmination of the continuous improvements and updates BitFlow has made to Camera Link frame grabbers.